Liquid biopsy to tailor the treatment of advanced hormone receptor-positive breast cancer in the era of novel endocrine agents and CDK4/6-inhibitors

Ann Transl Med. 2024 Feb 1;12(1):19. doi: 10.21037/atm-23-1804. Epub 2023 Oct 30.

Authors

Elia Seguí^{1

2

3}, Francesco Schettini^{2

3

4}

Affiliations

¹ SOLTI Cancer Research Group, Barcelona, Spain.
² Medical Oncology Department, Hospital Clinic of Barcelona, Barcelona, Spain.
³ Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (FRCB-IDIBAPS), Barcelona, Spain.
⁴ Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.

No abstract available

Keywords: CDK4/6-inhibitors; ESR1; bazedoxifene; endocrine resistance; liquid biopsy.

Publication types

Editorial
Comment